Report - ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS vial of powder contains 150 mg secukinumab. After reconstitution, 1 ml of solution contains 150 mg secukinumab. Secukinumab is a recombinant

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form